G. E. Pool

An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM).

P. Staats, T. Smith, E. Buchser, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival.

Thomas J. Smith, Thomas J Smith, P. Staats, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Psychopathology in heart transplant candidates.

W. F. Kuhn, S. Lippmann, W F Kuhn, 1988, The Journal of heart transplantation.